Skip to main content
TipRanks
Go Ultimate75% OFF

Zydus Wellness Limited (ZYDUSWELL) AI Stock Analysis

4 Followers
IN:ZYDUSWELL

Zydus Wellness Limited

(NSE:ZYDUSWELL)

Select Model
Rating:47Neutral
Price Target:INR 500.00â–²(6.42% Upside)
Action:reiterated
Date:10/01/26

The score is held back primarily by weakened earnings quality—sharp margin compression, reduced cash generation/cash conversion, and a step-up in leverage—despite strong FY2026 revenue growth. Technicals are also soft (below major moving averages with negative MACD), and valuation is a headwind due to a very high P/E and minimal dividend yield.

Positive Factors
Strong Revenue GrowthThe sharp FY2026 acceleration shows strong demand and improved market traction across the business. If sustained, higher sales can expand distribution scale, support brand investment, and create a stronger base for recovering profitability over the next several quarters.
Negative Factors
Sharp Margin CompressionThe sharp decline in net and EBIT margins indicates that strong sales growth is not currently translating proportionately into earnings. Persistent cost, pricing, or mix pressure would reduce reinvestment capacity and make future profit growth less dependable.

Zydus Wellness Limited (ZYDUSWELL) vs. iShares MSCI India ETF (INDA)

-20%-10%0%10%20%30%40%IN:ZYDUSWELL+4.18%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 149.52B
Dividend Yield
0.26%
Average Volume (3M)
25.85K
Price to Earnings (P/E)
60.7
Beta (1Y)
0.77
Revenue Growth
73.68%
EPS Growth
-2.88%
Country
India
Employees
1,008
Sector
General
Sector Strength
55
Industry
Packaged Foods

Zydus Wellness Limited Business Overview & Revenue Model

Company Description

Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free Na...

How the Company Makes Money

Zydus Wellness primarily makes money by selling branded health and wellness consumer products to distributors, retailers, and other trade partners, generating revenue from the invoiced sale of finished goods. Its key revenue streams are (1) branded p...

Zydus Wellness Limited Financial Statement Overview

Summary

Revenue growth was very strong in FY2026 (+37.9%), but profitability deteriorated meaningfully (net margin ~5.0% vs ~12.8% prior year; EBIT margin ~9.0% vs ~13.7%). Balance sheet risk increased with a sharp rise in leverage (debt-to-equity ~0.55 vs ~0.03), and cash generation weakened materially (operating cash flow ~₹1.41B vs ~₹3.8B; free cash flow ~₹0.39B vs ~₹3.14B), making cash conversion the main weak spot.

Income Statement

62Positive

Balance Sheet

55Neutral

Cash Flow

41Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue50.06B39.61B27.09B23.28B22.55B20.09B
Gross Profit27.68B19.34B10.77B8.87B10.96B7.41B
EBITDA6.62B4.75B3.99B3.08B3.32B3.55B
Net Income2.46B1.97B3.47B2.67B3.10B3.09B
Balance Sheet
Total Assets103.52B103.08B64.42B61.48B58.33B56.92B
Cash, Cash Equivalents and Short-Term Investments2.62B1.15B1.29B3.16B1.08B1.96B
Total Debt31.67B32.03B1.88B3.29B2.97B3.87B
Total Liabilities44.44B44.82B7.70B7.91B7.11B8.48B
Stockholders Equity59.08B58.26B56.72B53.58B51.23B48.44B
Cash Flow
Free Cash Flow0393.00M3.14B2.18B467.00M1.61B
Operating Cash Flow01.41B3.80B2.46B917.00M2.37B
Investing Cash Flow0-29.11B-2.24B-1.78B-849.00M-859.50M
Financing Cash Flow027.85B-1.86B-257.00M-1.39B-2.34B

Zydus Wellness Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price469.85

Price Trends

50DMA506.78Negative
100DMA527.61Negative
200DMA492.33Negative

Market Momentum

MACD-9.68Negative
RSI43.23Neutral
STOCH20.16Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ZYDUSWELL, the sentiment is Negative. The current price of 469.85 is below the 20-day moving average (MA) of 480.24, below the 50-day MA of 506.78, and below the 200-day MA of 492.33, indicating a bearish trend. The MACD of -9.68 indicates Negative momentum. The RSI at 43.23 is Neutral, neither overbought nor oversold. The STOCH value of 20.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ZYDUSWELL.

Zydus Wellness Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:ZYDUSWELL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:BRITANNIAIN:BRITANNIA69NeutralINR 1.15T42.85―1.90%9.73%15.27%
IN:NESTLEINDIN:NESTLEIND64NeutralINR 2.44T59.73―0.94%21.68%38.17%
IN:TATACONSUMIN:TATACONSUM63NeutralINR 1.07T62.80―0.93%14.68%24.77%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:PATANJALIIN:PATANJALI52NeutralINR 458.06B23.23―1.54%18.15%31.17%
IN:AWLIN:AWL51NeutralINR 213.15B18.43―0.61%18.01%6.60%
IN:ZYDUSWELLIN:ZYDUSWELL47NeutralINR 149.49B60.72―0.26%73.68%-2.88%

* General Sector Average

Performance Comparison

-40%-20%0%20%IN:ZYDUSWELLIN:AWLIN:BRITANNIAIN:NESTLEINDIN:PATANJALIIN:TATACONSUMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:ZYDUSWELL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:ZYDUSWELLZydus Wellness Limited469.8514.963.29%
IN:AWLAdani Wilmar Limited164.00-109.42-40.02%
IN:BRITANNIABritannia Industries Ltd4755.00-977.13-17.05%
IN:NESTLEINDNestle India Ltd.1264.507.610.61%
IN:PATANJALIPatanjali Foods Limited421.00-160.30-27.58%
IN:TATACONSUMTata Consumer Products Limited1079.00-90.12-7.71%

Zydus Wellness Limited Corporate Events

Zydus Wellness Board Clears June Quarter Unaudited Results, Resets Trading Window

Aug 4, 2026

Zydus Wellness Limited’s Board of Directors, acting on the Audit Committee’s recommendations, has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in line with SEBI’s Listing Obligations and Di...

Zydus Wellness Opens Special Window for Legacy Physical Share Transfers

Aug 1, 2026

Zydus Wellness Limited operates in the fast-moving consumer goods and healthcare-oriented wellness sector, offering a portfolio of nutrition, personal care and health products tailored to Indian consumers. The company is listed on both BSE and the Na...

Zydus Wellness Sets August 4 Virtual AGM, Tightens KYC and E-Voting Norms

Jul 12, 2026

Zydus Wellness has convened its 32nd Annual General Meeting for August 4, 2026, to be held via video conferencing and other audio-visual means, with all ordinary and special business to be conducted exclusively through electronic voting. The company...

Zydus Wellness Subsidiary Fined by Polish Tax Authority for Intrastat Filing Delays

Jul 11, 2026

Zydus Wellness has disclosed that Comfort Click Limited, its step-down wholly owned subsidiary in the United Kingdom, has received an order from the Polish tax authority alleging delays in filing Intrastat declarations for stock movements between Jan...

Zydus Wellness Senior Sales Head Resigns, Transition Planned to Protect Operations

Jul 3, 2026

Zydus Wellness Limited has announced the resignation of senior management member Lalit Ahuja, who served as Head – Sales for India and ISC, effective at the close of business on July 3, 2026. The company disclosed the development under SEBI’s listing...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 30, 2026